← Back to Search

Other

Autologous Blood Membrane Technique for Gum Recession

N/A
Recruiting
Led By Tannaz Shapurian, DMD, MSc
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial showed that using patient's own blood to prepare a membrane for gum recession treatment is a viable alternative to traditional surgery.

Who is the study for?
This trial is for adults over 18 who need treatment for gum recession at two or more sites but don't want a second surgical site or donor tissue. Smokers, pregnant individuals, those not consenting to recommended therapy, and anyone unable to follow up are excluded.Check my eligibility
What is being tested?
The study tests the use of patients' own blood prepared as a membrane versus traditional grafting from the roof of the mouth for treating gum recession. It's a split-mouth design, meaning each patient receives both treatments in different areas.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site where blood is drawn and where it's applied as a membrane, swelling, infection risk at both treated sites, and possible failure of grafting leading to continued exposure of tooth roots.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compare autologous PRF & Autogenous CTG

Trial Design

1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
Participants will receive the CTG procedure on one side and the PRF procedure on the other. Both are standard of care soft tissue grafting methods and a split mouth design is standard of care.

Find a Location

Who is running the clinical trial?

Tufts UniversityLead Sponsor
265 Previous Clinical Trials
661,824 Total Patients Enrolled
Tannaz Shapurian, DMD, MScPrincipal InvestigatorTufts University School of Dental Medicine

Media Library

Soft Tissue Grafting (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05633511 — N/A
Gum Recession Research Study Groups: All Participants
Gum Recession Clinical Trial 2023: Soft Tissue Grafting Highlights & Side Effects. Trial Name: NCT05633511 — N/A
Soft Tissue Grafting (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05633511 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the process of accepting applications for this research ongoing?

"As indicated by clinicaltrials.gov, this trial is actively enrolling participants as of now. It was initially posted on the 11th of January 2023 and modified at least once since then; its most recent edition being dated to December 1st 2023."

Answered by AI

What is the maximum capacity for this clinical study?

"Affirmative. According to information hosted on clinicaltrials.gov, this medical study is currently recruiting volunteers and has been since January 11th of 2023. The last update was made on December 1st of the same year. A total of 50 people need to be enrolled from a single site for this trial to be completed successfully."

Answered by AI
~29 spots leftby Dec 2025